title: Fulminant hepatitis in aplastic anemia: hepatitis G or ALG?
authors.forename: H
authors.initials: H
authors.lastname: Akan
authors.forename: N
authors.initials: N
authors.lastname: Konuk
authors.forename: S
authors.initials: S
authors.lastname: Fenkçi
authors.forename: I
authors.initials: I
authors.lastname: Dilek
authors.forename: R
authors.initials: R
authors.lastname: Idilman
authors.forename: S
authors.initials: S
authors.lastname: Tuncer
mesh_terms: D000293:Adolescent; D000741:Anemia, Aplastic / Q000150:complications* / Q000821:virology; D000961:Antilymphocyte Serum / Q000009:adverse effects*; D005260:Female; D018067:Flaviviridae; D006501:Hepatic Encephalopathy / Q000209:etiology* / Q000821:virology; D006510:Hepatitis B Antibodies / Q000032:analysis; D006525:Hepatitis, Viral, Human / Q000209:etiology / Q000821:virology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D012367:RNA, Viral / Q000032:analysis
chemical_list: D000961:Antilymphocyte Serum; D006510:Hepatitis B Antibodies; D007166:Immunosuppressive Agents; D012367:RNA, Viral